Malene Jensen
Directeur Technique/Scientifique/R&D chez MEDIVIR AB
Fortune : 7 162 $ au 31/05/2024
Provenance du réseau au premier degré de Malene Jensen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
12
| Public Company | Pharmaceuticals: Major | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Malene Jensen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Comptroller/Controller/Auditor | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The European Academy of Cancer Sciences
 The European Academy of Cancer Sciences Miscellaneous Commercial ServicesCommercial Services The European Academy of Cancer Sciences is an independent advisory body of medical specialists and researchers. The Swedish company's mission is to create a continuum of cancer research, from basic research to evidence-based cancer care and prevention. The private company provides evidence-based advice to inform policy and organize their work through scientific committees gathered around priority areas across the cancer spectrum. The Academy has consulted a wide range of cancer research, policy, and care specialists and patient organizations to formulate consensus advice to the cancer mission board. The company reached the consensus view that a comprehensive translational cancer research approach that is focused on personalized/precision medicine and that covers the entire cancer research, cancer care, and prevention continuum has the potential to achieve in 2030 the goal of a 10-year cancer-specific survival for 75%% of the patients diagnosed with cancer in EU member states with a well-developed healthcare system. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ZICCUM AB | Medical Specialties | Director/Board Member | |
| The Swedish Cancer Society | Corporate Officer/Principal | ||
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| Royal Society of Sciences | Corporate Officer/Principal | ||
| European Molecular Biology Organization | Corporate Officer/Principal | ||
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| HAMLET PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| Glycovisc BioTech AB | Corporate Officer/Principal | ||
| ELICERA THERAPEUTICS AB | Biotechnology | Director/Board Member | |
| Medivir Personal AB | Corporate Officer/Principal | ||
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
| Herder Consulting AB | Director/Board Member | ||
| IDOGEN AB (PUBL) | Biotechnology | Chief Executive Officer | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chief Executive Officer | |
| University of Stockholm | College/University | Masters Business Admin | |
| Royal Institute of Technology | College/University | Doctorate Degree | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| ALZECURE PHARMA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| van Es Consulting AB | Director/Board Member | ||
| University of East Anglia | College/University | Undergraduate Degree | |
| Faculty of Pharmaceutical Medicine | Director/Board Member | ||
| Cardiff Law School | College/University | Graduate Degree | |
| The University of Wales | College/University | Undergraduate Degree | |
| University of Gothenburg | College/University | Undergraduate Degree | |
Nanolyze AB
 Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Miscellaneous Commercial Services | Chairman | |
| XBRANE BIOPHARMA AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| COMBINEDX AB | Miscellaneous Commercial Services | Director/Board Member | |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Investor Relations Contact | |
| SEDANA MEDICAL AB | Medical Specialties | Chief Executive Officer | |
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member | |
ICA Sverige AB
 ICA Sverige AB Food DistributorsDistribution Services Part of ICA Gruppen AB, ICA Sverige AB is a company that wholesales food. ICA Sverige AB is based in Solna, Sweden. The Swedish company was founded in 1922. Eric Lundberg has been the CEO of the company since 2022. | Food Distributors | Corporate Officer/Principal | |
Rebtel Networks AB
 Rebtel Networks AB Packaged SoftwareTechnology Services Rebtel Networks AB provides communication services. It develops applications for iPhone, Androids, Windows phones, and other phones. The firm offers international calling card that provides way to set limits on spending when making numerous international calls, mobile top ups, international and voice over Internet protocol calling services and international short messaging services. The company was founded by Folke Hjalmar Birgersson Winbladh and Jonas Erik Ivar Lindroth in 2006 and is headquartered in Nacka Strand, Sweden. | Packaged Software | Director of Finance/CFO | |
O'Learys Trademark AB
 O'Learys Trademark AB RestaurantsConsumer Services Part of O'Learys Holding AB, O'Learys Trademark AB is a Swedish company that owns and operates a chain of restaurants. The company is based in Stockholm, Sweden. The company was founded by Jonas Reinholdsson and the CEO is Wilhelm Vintilescu. O'Learys Trademark was acquired by O'Learys Trademark/Management/ from SSP Sweden Financing AB on January 13, 2012. | Restaurants | Director of Finance/CFO | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member |
Statistiques
Internationale
| Suède | 38 |
| Royaume-Uni | 6 |
| Etats-Unis | 4 |
| Allemagne | 2 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 2 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 63 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 19 |
| Chairman | 14 |
| Chief Executive Officer | 12 |
Relations les plus connectées
- Bourse
- Insiders
- Malene Jensen
- Connexions Sociétés
